Results 181 to 190 of about 100,300 (318)

Tacrolimus combined with arsenic trioxide provides a three-in-one drug-eluting coronary stent integrating anti-restenosis, pro-endothelialization and anti-inflammation

Yaojia Zhang, Hongchi Yu, Li Deng, Zhé Hóu, Jie Yang, Fei Fang, Michael Z. Miao, Wenjun Li, Xin Shen, Dongyun Hao, Xiaoyi Ma, Lifeng Zhou, Fugui He, Xiaoheng Liu   +13 more
openalex   +1 more source

The cost-effectiveness of drug-eluting stents: a systematic review [PDF]

, 2006
Suzanne A. Ligthart, Floortje Vlemmix, Nandini Dendukuri, James M. Brophy   +3 more
openalex   +1 more source

Preclinical Assessment of a Novel Polymer-Free Hybrid Drug Eluting Stent. [PDF]

J Cardiovasc Transl Res
Wild L, Beele A, Seguchi M, Lenz T, Nicol P, Sabic-Halilcevic E, Klosterman GR, Kastrati A, Joner M.   +8 more
europepmc   +1 more source

A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).

Journal of the American College of Cardiology, 2014
F. Alfonso, Maria Jose Pérez-Vizcayno, Alberto Cárdenas, B. Garcia, Del Blanco, B. Seidelberger, A. Íñiguez, M. Gómez-Recio, M. Masotti, M. Teresa Velázquez, J. Sanchis, A. García-Touchard, J. Zueco, A. Bethencourt, R. Melgares, Á. Cequier, Antonio J Domínguez, V. Mainar, J. López-Mínguez, J. Moreu, V. Martí, R. Moreno, P. Jiménez-Quevedo, N. Gonzalo, C. Fernández, C. Macaya   +25 more
semanticscholar   +1 more source

Comparative Evaluation of Incidence of Cardiovascular Events Among Different Drug-Eluting Stent Features: A Retrospective Cohort Study. [PDF]

Health Sci Rep
Koushki H, Vafa RG, Heydarzadeh R, Zarifkar H, Hosseini AK, Zarifkar H, Zarifkar H, Azadian A, Amiri F, Mohammadhassani A, Montaseri M, Hosseini N, Sadeghi M, Hosseini SA, Mirhosseini SA, Kojuri J.   +15 more
europepmc   +1 more source

Are Everolimus-Eluting Stents Associated With Better Clinical Outcomes Compared to Other Drug-Eluting Stents in Patients With Type 2 Diabetes Mellitus?

, 2016
Pravesh Kumar Bundhun, Manish Pursun, Abhishek Rishikesh Teeluck, Manyun Long   +3 more
openalex   +1 more source

Impact of Stent Size Selection on Acute and Long-Term Outcomes After Drug-Eluting Stent Implantation in De Novo Coronary Lesions

Circulation. Cardiovascular Interventions, 2017
H. Kitahara, K. Okada, Takumi Kimura, P. Yock, A. Lansky, J. Popma, A. Yeung, P. Fitzgerald, Y. Honda   +8 more
semanticscholar   +1 more source

Percutaneous Treatment of a Giant Coronary Artery Aneurysm Using a Covered Stent With a Drug-Eluting Stent "Sandwich" Technique: A Case Report. [PDF]

Cureus
Umashankar A, Ali MH, Abdelmaaboud M, Ionescu A.   +3 more
europepmc   +1 more source

Drug Eluting Stents & Coronary Angiography

, 2006
Bharat Rawat, PR Poudel, Smriti Mulmi
openalex   +2 more sources

Threshold effect of systemic immune-response index on in-stent neoatherosclerosis among patients with drug-eluting stent restenosis. [PDF]

Eur J Med Res
Yang S, Xia Q, Gu N, Shen C, Deng C, Wang X, Deng Y, Hu X, Zhu J, Zhao R, Shi B.   +10 more
europepmc   +1 more source